SRPT stock rated an Outperform by BMO Capital Markets

Sarepta Therapeutics Inc’s recent filing unveils that its Director Boor Kathryn Jean unloaded Company’s shares for reported $93550.0 on Mar 11 ’24. In the deal valued at $122.93 per share,761 shares were sold. As a result of this transaction, Boor Kathryn Jean now holds 7,516 shares worth roughly $0.89 million. Then, Wigzell Hans Lennart Rudolf […]

SRPT short interest surges, indicating growing pessimism among investors

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Sarepta Therapeutics Inc shares valued at $93,550 were sold by Boor Kathryn Jean on Mar 11 ’24. At $122.93 per share, Boor Kathryn Jean sold 761 shares. The insider’s holdings dropped […]

Sarepta Therapeutics Inc [SRPT] Investment Appeal on the Rise

Sarepta Therapeutics Inc’s filing revealed that its Director Boor Kathryn Jean unloaded Company’s shares for reported $93550.0 on Mar 11 ’24. In the deal valued at $122.93 per share,761 shares were sold. As a result of this transaction, Boor Kathryn Jean now holds 7,516 shares worth roughly $0.95 million. Then, Wigzell Hans Lennart Rudolf sold […]

SRPT’s short interest surges to 4.97 million shares

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Sarepta Therapeutics Inc shares valued at $93,550 were sold by Boor Kathryn Jean on Mar 11 ’24. At $122.93 per share, Boor Kathryn Jean sold 761 shares. The insider’s holdings dropped to 7,516 shares […]

Taking a Closer Look At Sarepta Therapeutics Inc (SRPT) Following Its Recent Trade

CHWY Stock

Sarepta Therapeutics Inc’s filing revealed that its Director Boor Kathryn Jean unloaded Company’s shares for reported $93550.0 on Mar 11 ’24. In the deal valued at $122.93 per share,761 shares were sold. As a result of this transaction, Boor Kathryn Jean now holds 7,516 shares worth roughly $0.97 million. Then, Wigzell Hans Lennart Rudolf sold […]

A Guide To The Risks Of Investing In Sarepta Therapeutics Inc (SRPT)

Sarepta Therapeutics Inc’s recent filing unveils that its Director Boor Kathryn Jean unloaded Company’s shares for reported $93550.0 on Mar 11 ’24. In the deal valued at $122.93 per share,761 shares were sold. As a result of this transaction, Boor Kathryn Jean now holds 7,516 shares worth roughly $0.96 million. Then, Wigzell Hans Lennart Rudolf […]